CGL
DXCM icon

Clarius Group LLC’s DexCom DXCM Stock Holding History

Clarius Group LLC’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,328
Closed -$264K – 462
2024
Q2 		$264K Sell
2,328
-88
-4% -$11.1K 0.02% 346
2024
Q1 		$335K Sell
2,416
-376
-13% -$47.3K 0.02% 310
2023
Q4 		$346K Sell
2,792
-221
-7% -$22.6K 0.03% 316
2023
Q3 		$281K Sell
3,013
-1,015
-25% -$114K 0.03% 351
2023
Q2 		$518K Sell
4,028
-22
-0.5% -$2.66K 0.04% 249
2023
Q1 		$471K Sell
4,050
-8
-0.2% -$896 0.04% 271
2022
Q4 		$460K Buy
4,058
+111
+3% +$12.2K 0.04% 267
2022
Q3 		$318K Sell
3,947
-120
-3% -$10.2K 0.03% 324
2022
Q2 		$303K Buy
4,067
+1,571
+63% +$143K 0.03% 334
2022
Q1 		$335K Hold
2,496
– – 0.03% 335
2021
Q4 		$335K Buy
2,496
+348
+16% +$50K 0.03% 335
2021
Q3 		$294K Buy
2,148
+184
+9% +$23.2K 0.03% 322
2021
Q2 		$210K Buy
+1,964
New +$189K 0.02% 399
2020
Q4 		– Sell
-2,376
Closed -$245K – 354
2020
Q3 		$245K Buy
+2,376
New +$248K 0.03% 244

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Clarius Group LLC's DXCM Position: Q3 2024 in Review

Clarius Group LLC sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,328 shares — an estimated $264K sold.

Clarius Group LLC first reported a position in DXCM in Q3 2020 and held it in 14 quarters. The position peaked at $518K in Q2 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Clarius Group LLC reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Clarius Group LLC sold 2,328 DexCom shares in Q3 2024, an estimated $264K.
  • Clarius Group LLC first reported a position in DexCom in Q3 2020 and held it in 14 quarters.
  • Clarius Group LLC's DexCom position peaked at $518K in Q2 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Clarius Group LLC's 13F filing for Q3 2024, filed 9 Oct 2024.